The overall goal of the HMO Cancer Research Network (CRN), and the NCI initiative under which it was funded, is to enhance research on cancer prevention, early detection, treatment, long-term care and post-diagnosis monitoring in the context of health care delivery systems. For this competing continuation, we seek to further improve the research capacity of the CRN, and use it to conduct a broader array of cancer research studies that relate to NCI research priorities. This renewal proposal includes a number of modifications and enhancements to the CRN Infrastructure, in addition to three new research project proposals. These proposed changes to the CRN's Infrastructure and functioning are directed at increasing the quality and efficiency of the research, the extent of collaboration, and the ability to develop new research ideas and junior investigators. The project proposals capitalize on our rich data resources, interests and expertise of CRN investigators, and the research opportunities presented by large health care delivery systems with track records of innovation in cancer control. The three projects are: 1) Clinical and Pathologic Predictors for Recurrence after DCIS; 2) Making Effective Nutritional Choices for Cancer Prevention: the MENU Study; 3) Using Electronic Medical Records to Measure and Improve Adherence to Tobacco Treatment Guidelines in Primary Care.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Brown, Martin L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Group Health Cooperative
United States
Zip Code
Punglia, Rinaa S; Jiang, Wei; Lipsitz, Stuart R et al. (2018) Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat 167:751-759
Hassett, Michael J; Uno, Hajime; Cronin, Angel M et al. (2017) Survival after recurrence of stage I-III breast, colorectal, or lung cancer. Cancer Epidemiol 49:186-194
Kimmick, Gretchen G; Major, Brittny; Clapp, Jonathan et al. (2017) Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast Cancer Res Treat 163:391-398
Buist, Diana S M; Field, Terry S; Banegas, Matthew P et al. (2017) Training in the Conduct of Population-Based Multi-Site and Multi-Disciplinary Studies: the Cancer Research Network's Scholars Program. J Cancer Educ 32:283-292
Engmann, Natalie J; Ergas, Isaac J; Yao, Song et al. (2017) Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study. Cancer Epidemiol Biomarkers Prev 26:1466-1469
Yao, Song; Zhang, Yali; Tang, Li et al. (2017) Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat 161:501-513
Yao, Song; Kwan, Marilyn L; Ergas, Isaac J et al. (2017) Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. JAMA Oncol 3:351-357
Lieu, Tracy A; Ray, G Thomas; Prausnitz, Stephanie R et al. (2017) Oncologist and organizational factors associated with variation in breast cancer multigene testing. Breast Cancer Res Treat 163:167-176
Mazor, Kathleen M; Rubin, Donald L; Roblin, Douglas W et al. (2016) Health literacy-listening skill and patient questions following cancer prevention and screening discussions. Health Expect 19:920-34
Walsh, Kathleen; Ryan, Jamie; Daraiseh, Nancy et al. (2016) Errors and Nonadherence in Pediatric Oral Chemotherapy Use. Oncology 91:231-236

Showing the most recent 10 out of 188 publications